Reimagining AI's Role in Empowering Clinical Trial Stakeholders.
16TH MAY, 2024 • 3PM LONDON / 4PM PARIS / 10AM NEW YORK
The countdown is on! Register now for our webinar, starting in:
We tried fully digitizing our trials, and it didn’t work out. Now, as the relentless pace of AI promises another revolution, we look forward to harnessing this exciting technology not as a replacement for human management, but as a powerful tool that augments the expertise of clinical trial professionals.
This webinar delves into how AI, when thoughtfully designed and applied, can foster a symbiotic relationship with stakeholders, enhancing decision-making, improving operational efficiency, facilitating real-time insights, personalising interactions and rethinking patient engagement.
Our discussion will pivot around human-centric AI in drug development—where technology serves to empower rather than overshadow, ensuring that the clinical ecosystem becomes more efficient, adaptable, and finely attuned to the complex tapestry of human needs and behaviors.
Expect insights into how AI technologies can be leveraged to streamline operational processes and real-world examples to illustrate where AI is bringing such transformations, highlighting the benefits and challenges encountered along the way.
Join us to explore how we can champions both technological innovation and the indispensable human touch.
Camille Hertzka VP, Global Franchise Head, Oncology R&D AstraZeneca
Mohammed Ali M&D Head of Reporting Analytics and Insight Astellas
Shameer Khader Executive Director - Precision Medicine and Computational Biology Sanofi
Shawn Blackburn President YPrime Labs
Oliver Backhouse VP Partnerships Evinova/AstraZeneca
Paul Simms Chief Executive Impatient Health